NeoGenomics (FRA:NG9) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 11, 2026)


FRA:NG9 NeoGenomics Inc FRA:NG9
72 GF Score
Price €12.72
GF Value €14.99
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is NeoGenomics Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

NeoGenomics's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

FRA:NG9 vs WGS, CDNA, PSNL: Margin of Safety % (DCF Dividends Based) Comparison

For the Diagnostics & Research subindustry, NeoGenomics's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeoGenomics Margin of Safety % (DCF Dividends Based) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NeoGenomics's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where NeoGenomics's Margin of Safety % (DCF Dividends Based) falls into.


FRA:NG9
72GF Score
NeoGenomics Inc FRA:NG9
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is NeoGenomics (FRA:NG9) Overvalued in 2026?

Based on GuruFocus' analysis, NeoGenomics stock appears to be undervalued. The current stock price of €12.72 is trading 15.2% below its estimated GF Value™ of €14.99. GuruFocus considers NeoGenomics to be Fairly Valued.

Key valuation signals for FRA:NG9:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: €14.99 vs. price of €12.72 (15.2% below fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the FRA:NG9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NeoGenomics Business Description

Other Exchanges NEO:USANEO:Mexico
Address 9490 NeoGenomics Way, Fort Myers, FL, USA, 33912
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
72GF Score

Get the complete analysis for FRA:NG9

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.72
Price
€14.99
GF Value